Medifast (MED) Tops Q4 EPS by 148c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.05 -0.74%
Revenue Growth %: -24.3%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -24.3%
Financial Fact:
Cost of sales: 16.42M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $3.70, $1.48 better than the analyst estimate of $2.22. Revenue for the quarter came in at $337.2 million versus the consensus estimate of $330.1 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Champions Oncology (CSBR) Tops Q1 EPS by 6c
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
